EXHIBIT 99.1 Accountants' Consent The Board of Directors Lorus Therapeutics Inc. We consent to the use of our report dated July 3, 2003, included in this annual report on Form 40-F. /s/ KPMG LLP - ---------------------------------- Chartered Accountants Toronto, Canada November 18, 2003